CapsoVision Rebounds in Second Day of Trading

Dow Jones

Jul 04, 2025

By Kelly Cloonan

Shares of CapsoVision climbed in the medical-technology company's second day of trading on the Nasdaq.

The stock edged up 26%, to $4.41, midday Thursday, after ending Wednesday down following its trading debut.

CapsoVision said Thursday it closed its initial public offering of 5.5 million shares of common stock at $5 apiece. Prior to the IPO, the company anticipated a price range of $5 to $5.50 a share, according to filings with the Securities and Exchange Commission.

The gross proceeds from the offering before underwriting discounts, commissions and other expenses were $27.5 million, the Saratoga, Calif., company said.

Underwriters have been granted a 30-day option to purchase up to an additional 825,000 shares at the public offering price, the company said.

The Benchmark Company and Roth Capital Partners acted as joint book-running managers for the offering, the company said.

Write to Kelly Cloonan at kelly.cloonan@wsj.com

(END) Dow Jones Newswires

July 03, 2025 12:32 ET (16:32 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

LOGIN / SIGN UP

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2548389661"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2548389661\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2548389661?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-07-04 00:32","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2548389661","market":"fut","top_or_hot":-1,"title":"CapsoVision Rebounds in Second Day of Trading","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<pre>\n \n</pre>\n<p>\n  By <a href=\"https://laohu8.com/S/KELYA\">Kelly</a> Cloonan \n</p>\n<pre>\n \n</pre>\n<p>\n  Shares of CapsoVision climbed in the medical-technology company's second day of trading on the <a href=\"https://laohu8.com/S/NDAQ\">Nasdaq</a>. \n</p>\n<p>\n  The stock edged up 26%, to $4.41, midday Thursday, after ending Wednesday down following its trading debut. \n</p>\n<p>\n  CapsoVision said Thursday it closed its initial public offering of 5.5 million shares of common stock at $5 apiece. Prior to the IPO, the company anticipated a price range of $5 to $5.50 a share, according to filings with the Securities and Exchange Commission. \n</p>\n<p>\n  The gross proceeds from the offering before underwriting discounts, commissions and other expenses were $27.5 million, the Saratoga, Calif., company said. \n</p>\n<p>\n  Underwriters have been granted a 30-day option to purchase up to an additional 825,000 shares at the public offering price, the company said. \n</p>\n<p>\n  The Benchmark Company and Roth Capital Partners acted as joint book-running managers for the offering, the company said. \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to <a href=\"https://laohu8.com/S/KELYB\">Kelly</a> Cloonan at kelly.cloonan@wsj.com \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  July 03, 2025 12:32 ET (16:32 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>CapsoVision Rebounds in Second Day of Trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCapsoVision Rebounds in Second Day of Trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2025-07-04 00:32</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<pre>\n \n</pre>\n<p>\n  By <a href=\"https://laohu8.com/S/KELYA\">Kelly</a> Cloonan \n</p>\n<pre>\n \n</pre>\n<p>\n  Shares of CapsoVision climbed in the medical-technology company's second day of trading on the <a href=\"https://laohu8.com/S/NDAQ\">Nasdaq</a>. \n</p>\n<p>\n  The stock edged up 26%, to $4.41, midday Thursday, after ending Wednesday down following its trading debut. \n</p>\n<p>\n  CapsoVision said Thursday it closed its initial public offering of 5.5 million shares of common stock at $5 apiece. Prior to the IPO, the company anticipated a price range of $5 to $5.50 a share, according to filings with the Securities and Exchange Commission. \n</p>\n<p>\n  The gross proceeds from the offering before underwriting discounts, commissions and other expenses were $27.5 million, the Saratoga, Calif., company said. \n</p>\n<p>\n  Underwriters have been granted a 30-day option to purchase up to an additional 825,000 shares at the public offering price, the company said. \n</p>\n<p>\n  The Benchmark Company and Roth Capital Partners acted as joint book-running managers for the offering, the company said. \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to <a href=\"https://laohu8.com/S/KELYB\">Kelly</a> Cloonan at kelly.cloonan@wsj.com \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  July 03, 2025 12:32 ET (16:32 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"CV","symbol_name":"CapsoVision, Inc.","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2548389661","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2548389661","pubTimestamp":1751560320,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"Shares of CapsoVision climbed in the medical-technology company's second day of trading on the Nasdaq.The stock edged up 26%, to $4.41, midday Thursday, after ending Wednesday down following its trading debut.CapsoVision said Thursday it closed its initial public offering of 5.5 million shares of common stock at $5 apiece. Prior to the IPO, the company anticipated a price range of $5 to $5.50 a share, according to filings with the Securities and Exchange Commission.The gross proceeds from the offering before underwriting discounts, commissions and other expenses were $27.5 million, the Saratoga, Calif., company said.Underwriters have been granted a 30-day option to purchase up to an additional 825,000 shares at the public offering price, the company said.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"CV":"CapsoVision, Inc."},"translate_title":"CapsoVision在第二天交易中反弹","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CV":1},"content_text":"By Kelly Cloonan \n\n\n \n\n\n  Shares of CapsoVision climbed in the medical-technology company's second day of trading on the Nasdaq. \n\n\n  The stock edged up 26%, to $4.41, midday Thursday, after ending Wednesday down following its trading debut. \n\n\n  CapsoVision said Thursday it closed its initial public offering of 5.5 million shares of common stock at $5 apiece. Prior to the IPO, the company anticipated a price range of $5 to $5.50 a share, according to filings with the Securities and Exchange Commission. \n\n\n  The gross proceeds from the offering before underwriting discounts, commissions and other expenses were $27.5 million, the Saratoga, Calif., company said. \n\n\n  Underwriters have been granted a 30-day option to purchase up to an additional 825,000 shares at the public offering price, the company said. \n\n\n  The Benchmark Company and Roth Capital Partners acted as joint book-running managers for the offering, the company said. \n\n\n \n\n\n  Write to Kelly Cloonan at kelly.cloonan@wsj.com \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  July 03, 2025 12:32 ET (16:32 GMT)\n\n\n  Copyright (c) 2025 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}